Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
19.42
+0.10 (0.52%)
At close: Mar 20, 2026, 4:00 PM EDT
19.31
-0.11 (-0.57%)
After-hours: Mar 20, 2026, 6:31 PM EDT
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $2.77 billion as of March 20, 2026. Its market cap has increased by 1,114.78% in one year.
Market Cap
2.77B
Enterprise Value
2.46B
1-Year Change
1,114.78%
Ranking
Category
Stock Price
$19.42
Market Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has increased from $156.31M to $2.77B, an increase of 1,672.81%. That is a compound annual growth rate of 79.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 2.77B | 132.23% |
| Dec 31, 2025 | 1.19B | 259.49% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
| Apr 20, 2021 | 156.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alumis | 3.10B |
| Dyne Therapeutics | 3.06B |
| Telix Pharmaceuticals | 3.01B |
| Vera Therapeutics | 2.99B |
| IDEAYA Biosciences | 2.91B |
| Arcutis Biotherapeutics | 2.85B |
| Tarsus Pharmaceuticals | 2.83B |
| Viridian Therapeutics | 2.83B |